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Background: The extent to which uncomplicated obesity among an otherwise healthy middle-aged population is
associated with higher longitudinal health-care expenditures remains unclear.
Methods: To examine the incremental long-term health service expenditures and outcomes associated with
uncomplicated obesity, 9398 participants of the 1994–1996 National Population Health Survey were linked to
administrative data and followed longitudinally forward for 11.5 years to track health service utilization costs and
death. Patients with pre-existing heart disease, those who were 65 years of age and older, and those with self-
reported body mass indexes of <18.5 kg/m2 at inception were excluded. Propensity-matching was used to
compare obesity (+/− other baseline risk-factors and lifestyle behaviours) with normal-weight healthy controls.
Cost-analyses were conducted from the perspective of Ontario’s publicly-funded health care system.
Results: Obesity as an isolated risk-factor was not associated with significantly higher health-care costs as
compared with normal weight matched controls (Canadian $8,294.67 vs. Canadian $7,323.59, P = 0.27). However,
obesity in combination with other lifestyle factors was associated with significantly higher cumulative expenditures
as compared with normal-weight healthy matched controls (CAD$14,186.81 for those with obesity + 3 additional
risk-factors vs. CAD$7,029.87 for those with normal BMI and no other risk-factors, P < 0.001). The likelihood that
obese individuals developed future diabetes and hypertension also rose markedly when other lifestyle factors, such
as smoking, physical inactivity and/or psychosocial distress were present at baseline.
Conclusions: The incremental health-care costs associated with obesity was modest in isolation, but increased
significantly when combined with other lifestyle risk-factors. Such findings have relevance to the selection,
prioritization, and cost-effective targeting of therapeutic lifestyle interventions.
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Obesity accounts for nearly $80 billion per year and be-
tween 2% and 3% of total health care expenditures in
North America [1] a 6% to 45% relative increase in health
care expenditures when compared with age and gender
matched normal weight populations [2]. The incremental* Correspondence: david.alter@ices.on.ca
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reproduction in any medium, provided the orincreases in population-attributable costs have been
ascribed predominantly to the development of long-term
complications and their associated impacts on hospital-,
physician service-, and medication-related expenditures
[3-6]. Recent studies suggest that the growth in health sys-
tem expenditures attributable to obesity will, in fact, sur-
pass cigarette smoking, and become the predominant
public health issue in North America [7]
Nonetheless, there are several limitations associated
with previous research. First, few studies have disen-
tangled the independent effects of obesity from other risk-
factors and disease-related complications that arise overd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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population who are free of cardiovascular disease at incep-
tion, so that forthcoming health system expenditures re-
flect the emergence of new incident diseases that occur
during follow-up rather than pre-existing diseases already
present at baseline. Second, obesity’s associations with
health outcomes may vary according to age. For example,
obesity may be more strongly associated with diabetes,
hypertension, and mortality among middle-aged adults
than among the elderly [8-12]. Third, the impact of obesity
on health-care expenditures may vary according to the
presence or absence of other concomitant lifestyle beha-
viours. For example, the cost-implications associated with
obesity may be significantly greater among a physically in-
active individual than an individual who is physically ac-
tive [13-16]. In order to delineate costs attributable to
obesity itself, analyses must match or adjust for other
lifestyle factors. Finally, the feasibility, effectiveness, and
cost-effectiveness of obesity-related public health policy
interventions may be undermined by the tremendous bur-
den of obesity in the population and by the heterogeneity
in risk-factors profiles within obese populations [17-20].
Delineating high-risk, high-cost lifestyle risk-factor combi-
nations may help direct, focus, and target policy lifestyle
interventions for obesity.
Accordingly, the objective of our study was to examine
the cumulative longitudinal health system expenditures
and outcomes associated with obesity among a cohort of
middle-aged adults in Ontario Canada, all of whom were
free from cardiovascular disease at inception, and to com-
pare these data with propensity-matched normal weight
healthy controls. Our analyses were conducted from the
perspective of Ontario’s publically funded health care sys-
tem, which covers the costs of medical health care delivery
for all of it’s residents, as well as the costs for medications
among individuals’ 65 years of age and older.
Methods
Data sources
The Ontario Health Survey (OHS) was part of the 1996/
1997 National Population Health Survey (NPHS) [21] in-
volving all Canadian provinces. OHS participants were
identified by telephone through random digit dialing.
One adult from each contacted household was asked to
give information about health care utilization, chronic
health problems, social characteristics, and individual
and cumulative income levels for all inhabitants. The
survey excluded persons living in Indian Reserves, Can-
adian Forces bases, some remote areas of Ontario, and
in institutions or collective dwellings. Homeless persons
and those without access to a telephone were also
excluded. Linkage of the initial OHS sample to adminis-
trative databases required patients consent to link their
health card numbers to a population file in order totrack downstream health service utilization and mortal-
ity. While 90% of the initial survey sample provided con-
sent to link, valid health card numbers were present in
only 62% of the initial survey sample. When compared
to those in whom data linkage was not feasible, the
linked sample was older, more affluent, and had more
co-existing illnesses. However, the absolute differences
between linked and unlinked samples were small, and
have been reported elsewhere [22]. Physician visits were
tracked through the Ontario physician’s claims databases
(Ontario Health Insurance Plan), while cardiac proce-
dures and hospitalizations were obtained through hos-
pital discharge records (Canadian Institutes of Health
Information), and mortality was identified through a
vital statistics registry (Registered Persons Database).
Additional details regarding the linked population-based
sample have been reported elsewhere [22]. Costs related
to drug claims were available through the Ontario Drug
Benefits (ODB) formulary once individuals became ODB
eligible (i.e., reaching the age of 65 years during follow-
up or were in special programs such as welfare). The
subsequent development of diabetes and hypertension
were obtained using the validated Ontario Diabetes and
Ontario Hypertension Databases [23,24].
Study population
To ensure we examined a relatively homogenous
disease-free middle-aged population, we excluded all
individuals with known heart disease at baseline (as
identified using both self-report and retrospectively
linked administrative health records extending historic-
ally to 1988), those ≥ 65 years of age, and underweight
individuals (self-reported body mass indexes [BMI]
< 18.5 kg/m2) (Figure 1), given that the development
of chronic disease and health care expenditures in
these subgroups are likely mediated by factors other
than obesity alone [8-11].
Baseline socioeconomic, ethnicity, demographic factors
Survey respondents reported on total annual household
income as an 11-level categorical variable, which was re-
categorized into three income-subgroups as has been done
previously [22,25]. These include: low income (< $30,000
per year); intermediate income ($30,000-$49,999 per year);
and high income (≥ $50,000 per year). Information on eth-
nicity was obtained through self-report from one or more
categories of 12 ethnic/racial subgroups as defined by the
Canadian Census [26]. For our purposes, ethnic/racial data
were re-aggregated a priori into a binary predictor variable
of Caucasian or non-Caucasian.
Baseline clinical risk
Prior hospitalizations and baseline comorbidity were




No patients with pre-existing heart disease
11,791 
Age < 65 years with body mass index < 18.5 kg/m2
9398












Propensity-matched low physical activity cohorts
(N=4,336)
Figure 1 Study sample eligibility subdivided according to subgroups used in propensity analyses NPHS=National Population Health
Survey.
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(i.e., look-back period of 8 years per patient prior to co-
hort inception). For the purposes of our study, high alco-
hol consumption, defined as consuming ≥ 2 drinks per
day, served as a surrogate clinical marker rather than as
a lifestyle risk-factor (see below) given its association
with other chronic diseases, including an increased risk
of cancer in women [27]. However, re-classifying alcohol
consumption as a lifestyle rather than a clinical factor
did not alter our results.
Obesity and overweight
Individuals were classified as obese or overweight based
upon BMI as derived using self-reported height and weight.
Obesity was defined as a BMI≥30 kg/m2; overweight was
defined as a BMI of 25.0-29.9 kg/m2. Normal BMI was
defined as derived measures between 18.5-24.9 kg/m2.
Other lifestyle risk-factors
Self-reported physical activity (defined as the number of
days per month exercising for ≥ 15 minutes per session),
smoking status, and psychosocial distress served as other
lifestyle risk-factor comparators for our study. For the
purposes of this study, a sedentary lifestyle was defined
as a frequency of physical activity that fell below the me-
dian for the study sample (i.e., < 17 days per month).
Psychosocial distress was evaluated using the OHS
derived distress scale, which is based on a subset of
items from the Composite International Diagnostic
Interview in which scores ranged from 0 to 24, with
higher scores indicating greater degrees of distress. [26]Psychosocial distress was defined as scores above the
sample median (> 2) [28]. Varying threshold values to
define sedentary lifestyle, psychosocial distress, or both,
did not meaningfully alter our results.
Primary outcomes: health care utilization expenditures
Cumulative health care expenditures served as the pri-
mary outcome. In accordance with the Canadian Agency
for Drugs and Technologies in Health which recom-
mends that Canadian cost-analysis and/or comparative
effectiveness studies are assessed from the perspective of
the publically funded health care system [29], we focused
our Ontario cost-analyses to medically insured services.
We utilized a bottom-up approach when tallying the
health service costs for individuals over the entire study
duration of 11.5 years. Health service costs consisted of
all primary and specialty-care physician visits,
emergency-room visits, hospitalizations, invasive cardiac
testing, revascularization procedures, and medication
costs once individuals reached the age of 65 years (or if
incomes fell below the poverty thresholds) during fol-
low-up. Medication costs for individuals younger than
65 years old where not examined given that such expen-
ditures are not covered by Ontario’s publicly funded
health care system. Costs related to hospitalizations and
emergency room visits were estimated using the re-
source intensity weight (RIW) methodology, whereby
the cost is the product of the RIW associated with a par-
ticular case and the average cost per weighted case for
Ontario [30]. The Ontario Case Costing Initiative was
used to estimate the costs related to percutaneous
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gery [31]. All costs were adjusted to 2006 Canadian dol-
lars, using the Bank of Canada Consumer Price Index.
Secondary outcomes
Secondary outcomes included all-cause mortality, the
occurrence of acute myocardial infarction or death, and
the new development (incident cases) of diabetes and/or
hypertension during the follow-up period as identified
using the validated Ontario Diabetes and Ontario Hyper-
tension Databases [23,24].
Analytic techniques
A series of propensity-score-matched samples were con-
structed in which cumulative costs associated subjects
with obesity were compared against cumulative costs asso-
ciated with normal weight matched controls. PropensityTable 1 Baseline characteristics before propensity matching co
normal weight individuals (BMI 18.5-24.9 kg/m2), and compa
with normal weight persons (BMI 18.5-24.9 kg/m2)
Obese (N
Socio-ethno-demographic Male (%) 718 (5
Mean age (SD) 42.5
(11.5
Caucasian (%) 1296 (
High income (%) 553 (4
Intermediate income (%) 398 (2
Low income (%) 412 (3
Pre-existing disease Prior hospitalizations (%) 502 (3
Diabetes (%) 34 (2
Hypertension (%) 39 (2
Prior depression (%) 25 (1
High alcohol consumption† (%) 323 (2
Risk-factors Current smoking (%) 384 (2
Sedentary{ 777 (5
Psychological distress} 518 (3
0 other risk-factors None 302 (2
1 other risk-factor Sedentary-only{ 332 (2
Distressed-only} 131 (
Smoking-only 79 (5
2 other risk-factors Sedentary + distressed 214 (1
Sedentary + smoking 132 (
Distressed+ smoking 74 (5
3 other risk-factors Sedentary + distressed + smoking 99 (7
* Mantel-Haenszel Chi-Square for dichotomous outcomes; least squares regression w
† High alcohol consumption is defined as consumption exceeding the median level
matching) and consists of consuming≥ 2 drinks per day.
{ Sedentary lifestyle was defined as a frequency of physical activity that fell below t
for≥ 15 minutes per session).
} High psychological distress is defined as the number of individuals whose distress
exceeding the median for the entire cohort (a score of >2) regardless of subgroupanalyses allows for the balancing of baseline characteristics
between exposed (e.g.., obese) and un-exposed (e.g., nor-
mal weight controls) individuals. The advantage of pro-
pensity analyses is that outcome differences can be more
easily causally attributed to exposure rather than to con-
founding factors since the latter variables were balanced
between the two groups in a manner that is analogous to
that of a randomized clinical trial. In this study, each
exposed individual (e.g., an individual with obesity) was
matched in 1:1 fashion to a healthy normal weight control,
based on a series of important confounders such as age,
gender, socioeconomic status, smoking, physical activity,
psychosocial stress, and comordidity. The difference in
health care costs between the exposed and unexposed
“matched pair” is then determined. The differences in
costs between each matched pair were then tallied and
averaged throughout the entire matched-cohort. Costsmparing individuals who were obese (BMI>30 kg/m2) with
ring individuals who were overweight (BMI 25–29.9kg/m2)
=1,363) Overweight (N= 3,375) Normal (N= 4,660) P value*
2.7) 2,136 (63.3) 1,858 (39.9) <0.001
6 41.83 37.9 (11.5) <0.001
6) (11.69)
95.1) 3154 (93.5) 4247 (91.1) <0.001
0.6) 1581 (46.8) 2024 (43.4) 0.72
9.2) 979 (29.0) 1309 (28.1) 0.32
0.2) 815 (24.2) 1327 (28.5) 0.54
8.8) 1033 (30.6) 1670 (35.8) 0.19
.5) 62 (1.8) 41 (0.88) <0.001
.9) 42 (1.2) 25 (0.54) <0.001
.8) 32 (0.95) 63 (1.35) 0.60
3.7) 1070 (31.7) 1226 (26.3) 0.61
8.2) 998 (29.6) 1653 (35.5) <0.001
7.0) 1743 (51.6) 2277 (48.9) <0.001
8.0) 1098 (32.5) 1713 (36.8) 0.42
2.2) 837 (24.8) 1104 (23.7) 0.002
4.4) 831 (24.6) 897 (19.3)
9.6) 359 (10.6) 526 (11.3)
.8) 269 (8.0) 438 (9.4)
5.7) 350 (10.4) 480 (10.3)
9.7) 340 (10.1) 508 (10.9)
.4) 167 (5.0) 315 (6.8)
.3) 222 (6.6) 392 (8.4)
ith 1 degree of freedom of continuous outcomes (e.g., age).
for the entire cohort (regardless of subgroup and prior to propensity
he median for the study sample (i.e.,. < 17 days per month of exercising
scores, as measured using the Ontario Health Survey derived distress scale
and prior to propensity matching).
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against costs associated with their propensity-matched
non-risk factor counterparts (e.g.,. smokers were com-
pared with non-smoker match controls). When combining
multiple baseline risk-factors together, healthy subjects
with no risk-factors present at baseline served as
propensity-matched controls (Figure 1). Each person’s
propensity score was based on the following variables: age,
gender, ethnicity, socioeconomic status, prior hospitaliza-
tions, pre-existing diabetes, pre-existing hypertension,
pre-existing depression, alcohol consumption, physical ac-
tivity level (where appropriate), psychosocial distress
(where appropriate), and smoking (where appropriate).
Propensity-score matched samples were constructed by
using greedy nearest-neighbour matching with calipers of
width equal to 0.2 standard deviation of the logit of the
propensity score [32,33]. Statistical significance was
defined as two-tailed P< 0.05. Comparison of outcomes
between each risk factor group and normal controls were
made using paired t-Test and McNemar’s for continuous
and dichotomous variables respectively [34]. A series of
sensitivity analyses were conducted and are described in
the results.
All analyses utilized SAS v9.2 statistical software (SAS
Institute Inc Cary, NC, USA).
Results
Baseline data
Table 1 summarizes selected characteristics of patients
who were classified as obese, overweight, and normal
weight at baseline. The obese cohort was significantly
older and had a significantly higher prevalence of dia-
betes and hypertension; however, the prevalence of these
risk factors was low (2.5% and 2.9%, respectively). Most
subjects had at least one additional lifestyle risk-factor
beyond increased BMI, with sedentary lifestyle being the
most common, which had a significantly greater preva-
lence among obese than non-obese subgroups
(P < 0.001). Over 30% of patients had multiple risk-
factors (≥ 2) independent of BMI.
Relationship between obesity and long-term
expenditures
The median health care expenditures experienced by an
individual throughout the study period was [CAD]
$3182.54 (IQR = $8881.81; Q25%= $1023.15 and Q75% =
$9904.96]. Table 2 shows the baseline characteristics of
obese (and overweight) populations as compared with
normal weight controls, following propensity-matching
where the distribution of baseline covariates were well-
balanced between the two groups. The baseline charac-
teristics associated with smokers, distressed, and seden-
tary populations are shown in Additional file 1. Although
there was a trend toward higher health careexpenditures, obesity was not associated with signifi-
cantly higher cumulative costs as compared with
propensity-matched normal weight controls (CAD
$8,294.67 vs. CAD$7,323.59 per person over 11.5 years
of follow-up, P = 0.27). In contrast, those categorized as
smokers or psychologically distressed had significantly
higher health care expenditures over 11.5 years of follow-
up than their corresponding non-smoking, non-
distressed propensity-matched controls (Table 3).
Additional file 2 illustrates the baseline characteristics
after propensity matching for patients with multiple
risk-factors. In contrast to isolated risk-factors, health-
care expenditures were significantly greater among over-
weight and obese individuals as compared with normal
weight healthy controls when multiple lifestyle risk-
factors were present. For example, when combined with
smoking and/or psychological distress, an overweight in-
dividual had costs that were approximately CAD$2000
greater over 11.5 years than did a matched normal
weight individual with no other risk-factors present at
baseline. Similarly, an obese individual with other life-
style risk-factors present had between CAD$2,700 to
CAD$7,000 higher costs over 11.5 years than did a
matched normal weight individual with no other risk-
factors present at baseline (Table 4).
As sensitivity analyses, we examined the relationship
between BMI and longitudinal health care expenditures
using more traditional analytic techniques. We did so
among the original sample of 11,791 individuals regard-
less of missing data, and among the subgroup of 9,398
individuals for whom complete information were avail-
able for all. Our results did not change. Using Ordinary
Least Squares regression, age and female sex were the
strongest predictors of costs, accounting for 5% of the
variation in individual long-term expenditures
(R2 = 0.005). BMI, when examined either crudely or after
adjustment for age, gender, prior hospitalizations, and
risk-factors, was not significantly associated with individ-
ual long-term health care expenditures (ß = 32.8,
p = 0.49). A series of re-analyses in which we explored
various cut-points of BMI (i.e.., BMI exceeding 25 kg/
m2 or 30 kg/m2) and other analytic techniques includ-
ing Poisson and Logistic regression (i.e.., with the latter
having the binary outcome of higher vs. lower than me-
dian expenditures) yielded similar findings as above.
Secondary clinical outcomes
Table 5 illustrates the relationship between obesity and
secondary outcomes. Obese individuals had significantly
higher rates of death (4.6% vs. 2.1% for obese vs. normal
weight, P = 0.004) and AMI or death (6.1% vs. 2.8% for
obese vs. normal weight, P = 0.001) as compared with
normal weight propensity-matched controls. The devel-
opment of incident diabetes and hypertension during
Table 2 Baseline characteristics after propensity matching comparing individuals who were obese (BMI>30 kg/m2) with
normal weight individuals (BMI 18.5-24.9 kg/m2), and comparing individuals who were overweight (BMI 25–29.9kg/m2)















Male (%) 1,439 (49.7) 1,429 (49.3) 0.01 340 (41.4) 346 (42.1) 0.01
Mean age (SD) 39.2 (11.7) 39.2 (11.6) 0.00 39.4 (11.5) 38.6 (11.4) 0.05
Caucasian (%) 2,681 (92.6) 2,699 (93.2) 0.02 748 (91.0) 757 (92.1) 0.04
High income (%) 1,299 (44.9) 1,277 (44.1) 0.01 357 (43.4) 378 (46.0) 0.05
Intermediate income
(%)
845 (29.2) 854 (29.5) 0.00 229 (27.9) 231 (28.1) 0.01
Low income (%) 752 (26.0) 765 (26.4) 0.02 236 (28.7) 236 (28.7) 0.06
Prior hospitalizations
(%)
945 (32.7) 907 (31.4) 0.03 290 (35.3) 266 (32.4) 0.06
High alcohol
consumption* (%)
842 (29.1) 823 (28.4) 0.01 209 (25.4) 219 (25.4) 0.03
Diabetes (%) 35 (1.2) 26 (0.9) 0.03 10 (1.2) 11 (1.3) 0.01
Hypertension (%) 23 (0.8) 13 (0.4) 0.04 8 (1.0) 2 (0.2) 0.09
High depression (%) 32 (1.1) 33 (1.1) 0.00 12 (1.5) 15 (1.8) 0.03
Current smoking (%) 963 (33.3) 933 (32.2) 0.02 260 (31.6) 220 (26.8) 0.11
Sedentary† 1,478 (51.1) 1,475 (51.1) 0.00 414 (50.4) 405 (49.3) 0.02
Psychological distress{ 1,009 (34.8) 993 (34.3) 0.01 317 (38.6) 288 (35.0) 0.07
* High alcohol consumption is defined as consumption exceeding the median level for the entire cohort (regardless of subgroup and prior to propensity
matching) and consists of consuming≥ 2 drinks per day.
† Sedentary lifestyle was defined as a frequency of physical activity that fell below the median for the study sample (i.e.,. < 17 days per month of exercising
for≥ 15 minutes per session).
{ High psychological distress is defined as the number of individuals whose distress scores, as measured using the Ontario Health Survey derived distress scale
exceeding the median for the entire cohort (a score of >2) regardless of subgroup and prior to propensity matching).
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individuals as compared with normal weight controls.
However, when combined with at least one other life-
style risk factor at baseline, obese individuals had a sig-
nificantly higher rate of future (incident) diabetes and
hypertension as compared with normal weight controls.
For example, subjects who were obese, smokers, and
sedentary had a nearly 9-fold higher rate of developing
diabetes, a 2-fold higher rate of developing hypertension,
and a 2-fold higher risk of experiencing an adverse out-
come over the 11.5 year follow-up than did normal-
weight non-smoker, non-sedentary matched control.
Discussion
Our findings suggest that obesity as an isolated risk-
factor in a middle-aged population was not associated
with significantly higher incremental health care expen-
ditures. However, obesity when combined with other
baseline lifestyle risk-factors (e.g., psychological distress,
physical inactivity, and/or smoking) was associated with
significant increased cumulative costs as compared with
normal weight propensity-matched healthy controls(with no other lifestyle risk-factors present at baseline).
The risk of developing diabetes and hypertension during
follow-up increased with multiple lifestyle factors, and
was associated with higher expenditures.
Until now, few studies have attempted to examine longi-
tudinal costs associated with obese adult populations from
a point in time which preceded cardiovascular disease and
its related complications [1,35]. As a result, previous stud-
ies may have spuriously attributed costs of other risk-fac-
tors, other lifestyle behaviours and/or other chronic
disease to obesity thereby overestimating obesity-related
expenditures [36]. Such methodological limitations may
explain why obesity has been associated with higher ad-
verse events in some studies, and lower adverse events in
others [9,37-40]. Differences in obesity-related outcomes
(and their associated expenditures) are likely more
dependent on the constellation of lifestyle risk-factor
behaviours and their longitudinal progression to disease,
than on excess adiposity, body weight, or body-mass index
as identified at any single point in time.
Our methodological longitudinal cohort design which
excluded patients with cardiovascular disease, older adults (≥
Table 3 Health care expenditures among obese, overweight, smokers, distressed, and those with sedentary lifestyles
(each compared to their corresponding propensity-matched controls)*
Health service expenditures
CAD $







Total cost (SD) 8,294.67 (19,836.89) 7,323.59 (16,319.45) 0.27
Hospitalization costs (SD) 5,579.27 (17,703.04) 4,817.31 (13,976.07) 0.33
Physician visit costs (SD) 1,347.11 (1,503.19) 1,298.95 (1,374.94) 0.49
Drug costs (SD) 4,166.72 (5,501.10) 4,635.79 (6,421.78) 0.35









Total cost (SD) 7,138.16 (18,443.25) 6,866.16 (17,697.33) 0.56
Hospitalization costs (SD) 4,678.35 (16,460.79) 4,362.34 (15,810.42) 0.46
Physician visit costs (SD) 1,186.89 (1,107.21) 1,226.22 (1,328.81) 0.21
Drug costs (SD) 4,408.64 (6,087.27) 4,863.85 (6,327.79) 0.12
Cardiac procedural costs (SD) 199.94 (1,767.63) 188.67 (1,602.24) 0.80
Smokers (N = 2,966) Matched non-smoker controls (N = 2,966)
Total cost (SD) 8,626.50 (21,597.33) 7,299.83 (19,696.90) 0.004
Hospitalization costs (SD) 6,001.27 (19,183.45) 4,779.86 (17,320.47) 0.01
Physician visit costs (SD) 1,269.20 (1,365.92) 1,242.50 (1,279.84) 0.42
Drug costs (SD) 5,310.55 (6,945.39) 4,841.21 (6,643.73) 0.33
Cardiac procedural costs (SD) 334.81 (2,216.06) 164.71 (1,501.69) <0.001
Distressed (N = 3,239) Matched non-distressed controls (N = 3,239)
Total cost (SD) 8,454.12 (20,932.08) 7,131.86 (19,073.29) 0.007
Hospitalization costs (SD) 5,575.40 (18,489.80) 4,726.94 (17,050.19) 0.05
Physician visit costs (SD) 1,453.16 (1,552.62) 1,168.33 (1,125.90) <0.001
Drug costs (SD) 5,547.66 (7,210.97) 4,931.83 (6,920.64) 0.37
Cardiac procedural costs (SD) 249.56 (1,898.72) 192.45 (1,654.15) 0.20
Sedentary (N = 4,302) Matched non-sedintary controls(N = 4,302)
Total cost (SD) 8,087.56 (19,681.31) 7,846.43 (20,749.90) 0.58
Hospitalization costs (SD) 5,224.70 (17,026.70) 5,111.80 (18,627.41) 0.76
Physician visit costs (SD) 1,275.04 (1,248.92) 1,266.49 (1,309.95) 0.75
Drug costs (SD) 5,341.78 (6,878.87) 4,837.28 (6,565.49) 0.22
Cardiac procedural costs (SD) 294.54 (2,184.06) 194.21 (1,651.09) 0.22
* High alcohol consumption is defined as consumption exceeding the median level for the entire cohort (regardless of subgroup and prior to propensity
matching) and consists of consuming≥ 2 drinks per day.
Sedentary lifestyle was defined as a frequency of physical activity that fell below the median for the study sample (i.e.,. < 17 days per month of exercising for≥ 15
minutes per session).
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allowed for obesity-related expenditures to be compared
against normal weight controls from an inception point in
which most individuals had yet developed disease-related
complications. Moreover, the implementation of a
propensity-matched design further balanced baseline charac-
teristics, thereby allowing obesity to be examined within thecontext of other lifestyle factors thereby minimizing con-
founding. Such methods may have explained why obesity,
when examined as an isolated risk-factor in a middle-aged
population, failed to be associated with significant incremen-
tal expenditures as compared with matched controls.
Our results also demonstrated that incremental cumu-
lative health care expenditures associated with body


































controls (N = 2,896)
6,866.16
(17,697.33)
Normal weight healthy matched
controls (N = 822)
7,323.59
(16,319.45)












controls (N = 971)
6,826.64
(18,575.46)
Normal weight healthy matched























0.11 0.007 Obese+ distressed (N = 508) 12,788.78 (26,685.21) 0.22 <0.001
Normal weight
healthy matched
controls (N = 1089)
6,579.22
(16,900.57)
Normal weight healthy matched
controls (N = 508)
7,546.57
(19,592.65)
Three lifestyle risk-factors Three lifestyle risk-factors
Overweight + smoking
+ sedentary (N = 535)
9,216.40
(19,452.87)
0.10 0.08 Obese+ smoking+ sedentary (N = 229) 11,317.21 (22,818.74) 0.11 0.22
Normal weight
healthy matched
controls (N = 535)
7,190.30
(19,885.19)
Normal weight healthy matched




+ distressed (N = 380)
9,465.67
(19,412.22)
0.19 0.009 Obese+ smoking+ distressed (N = 167) 11,749.28 (23,476.53) 0.26 0.02
Normal weight
healthy matched
controls (N = 380)
6,026.03
(17,524.67)
Normal weight healthy matched




+ sedentary (N = 566)
8,393.17
(17,643.75)
0.12 0.04 Obese + distressed + sedentary (N = 302) 14,186.81 (30,536.44) 0.30 <0.001
Normal weight
healthy matched
controls (N = 566)
6,524.60
(13,856.13)
Normal weight healthy matched
controls (N = 302)
7,029.87
(14,931.77)
* High alcohol consumption is defined as consumption exceeding the median level for the entire cohort (regardless of subgroup and prior to propensity
matching) and consists of consuming≥ 2 drinks per day. Sedentary lifestyle was defined as a frequency of physical activity that fell below the median for the
study sample (i.e.,. < 17 days per month of exercising for≥ 15 minutes per session). High psychological distress is defined as the number of individuals whose
distress scores, as measured using the Ontario Health Survey derived distress scale exceeding the median for the entire cohort (a score of >2) regardless of
subgroup and prior to propensity matching).
†STD of the mean = Standardized Difference of the Mean.
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http://www.biomedcentral.com/1472-6963/12/238habitus rose substantially when BMI ≥ 25.0 kg/m2 was
combined with other lifestyle risk-factors. For example,
overweight and obese individuals who had 3 other life-
style risk-factors (i.e.., sedentary lifestyle, cigarette smok-
ing, psychologically distressed) had on average, $1,868
and $7,156 higher total expenditures respectively over
11.5 years of follow-up, than did propensity-matched
normal weight healthy controls. In this respect, ourresults are consistent with others demonstrating the in-
cremental cost implications associated with multiple as
compared with isolated risk-factors [41].
Despite having only modest economic consequences,
our results reaffirmed the importance of obesity as an
isolated prognostic risk-factor of clinical outcomes of
death, acute myocardial infarction, diabetes, and hyper-
tension [42]. However, the development of chronic
Table 5 The development of future (incident) diabetes, future (incident) hypertension, and death over 11.5 years of





P value Hypertension STD
of the
mean










Obese (N = 822) 7.2% 0.03 0.55 17.0% 0.07 0.16 6.1% 0.16 0.001 4.6% 0.14 0.004
Normal weight
healthy matched
controls (N = 822)
6.4% 14.6% 2.8% 2.1%
Two lifestyle risk-factors
Obese + smoking (N = 381) 21.3% 0.57 <0.001 26.8% 0.32 <0.001 8.9% 0.16 0.03 6.0% 0.08 0.25
Normal weight
healthy matched
controls (N = 381)
3.1% 14.2% 5% 4.2%
Obese+ sedentary
(N = 765)
21.7% 0.49 <0.001 32.4% 0.39 <0.001 7.5% 0.09 0.07 5.4% 0.06 0.25
Normal weight
healthy matched
controls (N = 765)
5.4% 17.6% 5.4% 4.2%
Obese + distressed
(N = 508)
21.3% 0.55 <0.001 30.3% 0.33 <0.001 9.3% 0.13 0.04 7.3% 0.09 0.15
Normal weight
healthy matched
controls (N = 508)
3.7% 16.5% 5.9% 5.1%
Three lifestyle risk-factors
Obese + smoking
+ sedentary (N = 229)
23.6% 0.65 <0.001 28.8% 0.37 <0.001 10% 0.24 0.006 6.6% 0.14 0.13
Normal weight
healthy matched
controls (N = 229)
2.6% 14% 3.9% 3.5%
Obese + smoking
+ distressed (N = 167)
21.6% 0.62 <0.001 25.1% 0.40 <0.001 9.6% 0.16 0.13 7.8% 0.12 0.22
Normal weight
healthy matched
controls (N = 167)
2.4% 10.2% 5.4% 4.8%
Obese+ distressed
+ sedentary (N = 302)
22.2% 0.56 <0.001 33.8% 0.33 <0.001 9.6% 0.16 0.01 7.3% 0.18 0.03
Normal weight
healthy matched
controls (N = 302)
4.0% 19.5% 5.0% 3.6%
*High alcohol consumption is defined as consumption exceeding the median level for the entire cohort (regardless of subgroup and prior to propensity matching)
and consists of consuming≥ 2 drinks per day. Sedentary lifestyle was defined as a frequency of physical activity that fell below the median for the study sample
(i.e.,. < 17 days per month of exercising for≥ 15 minutes per session). High psychological distress is defined as the number of individuals whose distress scores,
as measured using the Ontario Health Survey derived distress scale exceeding the median for the entire cohort (a score of >2) regardless of subgroup and prior
to propensity matching).
†STD of the mean = Standardized Difference of the Mean.
{AMI or death =Acute myocardial infarction or death.
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http://www.biomedcentral.com/1472-6963/12/238diseases (i.e.., incident diabetes and hypertension) as
with the risk of death or acute myocardial infarction rose
markedly when individuals with obesity had other ad-
verse lifestyle factors already present at baseline. As
with costs above, the longitudinal clinical risks asso-
ciated obesity depended upon other pre-existing lifestyle
factors - - a finding consistent with other studies [43-46].We believe our study highlights the merits of risk -
screening and risk-stratification using global health risk
assessment tools that capture multiple lifestyle beha-
viours. For example, in our study, obese populations
could be further stratified into higher risk, higher cost
subgroups, through the identification of other adverse
lifestyle behaviours. The broader implementation of
Alter et al. BMC Health Services Research 2012, 12:238 Page 10 of 12
http://www.biomedcentral.com/1472-6963/12/238health risk-assessments, which can identify and stratify
individuals based on several lifestyle risk-factors may
theoretically allow for more effective and cost-effective
targeting of obese populations for therapeutic lifestyle
interventions. Based on our study results, such targeted
populations should include those individuals who are
also physically inactive, who smoke, and/or are experi-
ence psychosocial distress.
Limitations
We recognize several noteworthy limitations to our
study methodology. First, ours was an observational
study. While randomization would not have been ethical
or feasible, propensity scores cannot consider and match
for unmeasured confounders. It is possible that unmeas-
ured confounders may have accounted for our results.
Second, BMI as with physical activity was based on
self-report and assessed at one point in time, which may
have biased our results towards the null. BMI does not
take into account central obesity or adiposity, which
may be more important prognostic and cost indicators
[47]. However, numerous other epidemiologic studies
have adopted similar methodology for characterizing
body habitus.
Third, medical expenditures were derived from health
service utilization encounters, which were captured using
administrative data. Only a subset of total expenditures
was examined in this study. For example, medical labora-
tory and other diagnostic imaging tests were not included
in our analysis. Moreover, limitations of administrative
data include the lack clinical detail and the inability to
identify drug-claims for individuals under the age of
65 years (unless an individual’s annual incomes fall below
the poverty thresholds). Nonetheless, administrative data
for health service utilization is comprehensive, and our
cost analysis was conducted from the publicly-funded
health care system perspective in accordance with Canad-
ian economic evaluative guidelines [29]. Finally, we did
examine data related to the three highest health care-
related publicly-funded health-care expenditures in
Canada and elsewhere (hospitalizations, physician visits,
and medications), which represented a comprehensive es-
timate of the economic-consequences of obesity on Cana-
da’s publicly-funded health care system.
Finally, our study examined a healthier subset of a rep-
resentative national population health survey. Ethnic mi-
norities and immigrants were under-represented, and
the representative of the population health survey is fur-
ther limited by the fact that only 30% of the original sur-
vey was included in the survey. Moreover, all individuals
were free of cardiovascular disease and were younger
than 65 years old at inception. Our results might have
differed had we examined a population at more at
advanced stages of life and disease. However, our intentwas to examine a subgroup of the middle-aged popula-
tion from a time point that preceded the development of
disease-related complication, so that we could better dis-
entangle the natural history of obesity from those of
other lifestyle behaviours.Conclusion
In conclusion, our study demonstrated that the incre-
mental long-term medical expenditures associated with
obesity among a middle-aged population are modest as
compared with propensity-matched normal weight
controls. However, incremental costs markedly rose
when obesity (or overweight body mass index) was
combined with other concomitant adverse lifestyle
behaviours. Such findings reinforce the need for com-
prehensive health risk stratification and have relevance
to the selection, prioritization, and cost-effective target-
ing of therapeutic lifestyle interventions for policy-
makers and system-planners.Additional files
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